Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Fidia Spa ( (IT:FDA) ) has issued an announcement.
Fidia S.p.A. has reported the conversion of three bonds from the seventh tranche of its convertible bond loan with warrants, reserved for Global Growth Holding Limited, into 6,000,000 new shares at a conversion price of €0.005 per share. The new shares are immediately admitted to trading on the regulated market under the existing prospectus, reinforcing the company’s equity base.
Following this operation, the capital increase linked to the POC has reached €1,560,000 of a total nominal subscription of €1,750,000, with 19 bonds in the seventh tranche still outstanding and not yet converted. As a result, Fidia’s share capital rises by €30,000 to €11,407,761.90, and the total number of shares increases to 123,078,639, modestly diluting existing shareholders while advancing the company’s ongoing financing plan.
More about Fidia Spa
Fidia S.p.A., based in Turin and listed on Euronext Milan, is a global leader in the design, production and sale of high-performance integrated milling systems. With more than 50 years of experience and around 135 employees, the group supplies numerical controls, high-speed milling systems and CAM software, serving mainly the automotive moulds and aerospace sectors worldwide.
YTD Price Performance: -91.67%
Average Trading Volume: 3,437,432
Technical Sentiment Signal: Strong Sell
Current Market Cap: €682.4K
For an in-depth examination of FDA stock, go to TipRanks’ Overview page.
